{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T21:12:54Z","timestamp":1768511574260,"version":"3.49.0"},"posted":{"date-parts":[[2024,4,28]]},"group-title":"Neuroscience","reference-count":33,"publisher":"openRxiv","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,4,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>\n                  Huntington\u2019s disease (HD) is an autosomal dominant neurodegenerative disease caused by CAG repeat expansion in the first exon of the huntingtin gene (\n                  <jats:italic>HTT<\/jats:italic>\n                  ). Oligonucleotide therapeutics, such as short interfering RNA (siRNA), reduce levels of huntingtin mRNA and protein\n                  <jats:italic>in vivo<\/jats:italic>\n                  and are considered a viable therapeutic strategy. However, the extent to which they silence HTT mRNA in the nucleus is not established. We synthesized siRNA cross-reactive to mouse (wild-type)\n                  <jats:italic>Htt<\/jats:italic>\n                  and human (mutant)\n                  <jats:italic>HTT<\/jats:italic>\n                  in a di-valent scaffold and delivered to two mouse models of HD. In both models, di-valent siRNA sustained lowering of wild-type\n                  <jats:italic>Htt<\/jats:italic>\n                  , but not mutant\n                  <jats:italic>HTT<\/jats:italic>\n                  mRNA expression in striatum and cortex. Near-complete silencing of both mutant HTT protein and wild-type Htt protein was observed in both models. Subsequent fluorescent in situ hybridization (FISH) analysis shows that di-valent siRNA acts predominantly on cytoplasmic mutant\n                  <jats:italic>HTT<\/jats:italic>\n                  transcripts, leaving clustered mutant\n                  <jats:italic>HTT<\/jats:italic>\n                  transcripts in the nucleus largely intact in treated HD mouse brains. The observed differences between mRNA and protein levels, exaggerated in the case of extended repeats, might apply to other repeat-associated neurological disorders.\n                <\/jats:p>","DOI":"10.1101\/2024.04.24.590997","type":"posted-content","created":{"date-parts":[[2024,4,28]],"date-time":"2024-04-28T15:45:15Z","timestamp":1714319115000},"source":"Crossref","is-referenced-by-count":2,"title":["mRNA nuclear clustering leads to a difference in mutant huntingtin mRNA and protein silencing by siRNAs\n                  <i>in vivo<\/i>"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5776-4285","authenticated-orcid":false,"given":"Sarah","family":"Allen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0012-5623","authenticated-orcid":false,"given":"Daniel","family":"O\u2019Reilly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4594-0640","authenticated-orcid":false,"given":"Rachael","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0905-4940","authenticated-orcid":false,"given":"Ellen","family":"Sapp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5425-0457","authenticated-orcid":false,"given":"Ashley","family":"Summers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Paquette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1040-0855","authenticated-orcid":false,"given":"Dimas Echeverria","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6966-7696","authenticated-orcid":false,"given":"Brianna","family":"Bramato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"McHugh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5714-8298","authenticated-orcid":false,"given":"Ken","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil","family":"Aronin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marian","family":"DiFiglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6928-8071","authenticated-orcid":false,"given":"Anastasia","family":"Khvorova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2024043012151309000_2024.04.24.590997v1.1","doi-asserted-by":"publisher","DOI":"10.1111\/ene.13413"},{"key":"2024043012151309000_2024.04.24.590997v1.2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90585-E"},{"key":"2024043012151309000_2024.04.24.590997v1.3","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(10)70245-3"},{"key":"2024043012151309000_2024.04.24.590997v1.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.06.036"},{"key":"2024043012151309000_2024.04.24.590997v1.5","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddg169"},{"key":"2024043012151309000_2024.04.24.590997v1.6","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.neuron.2022.01.006","article-title":"Uninterrupted CAG repeat drives striatum-selective transcriptionopathy and nuclear pathogenesis in human Huntingtin BAC mice","volume":"110","year":"2022","journal-title":"Neuron"},{"key":"2024043012151309000_2024.04.24.590997v1.7","first-page":"fcac248","article-title":"Mutant huntingtin messenger RNA forms neuronal nuclear clusters in rodent and human brains","volume":"4","year":"2022","journal-title":"Brain Commun"},{"key":"2024043012151309000_2024.04.24.590997v1.8","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awac241"},{"key":"2024043012151309000_2024.04.24.590997v1.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2008.12.023"},{"key":"2024043012151309000_2024.04.24.590997v1.10","doi-asserted-by":"publisher","DOI":"10.1038\/d41573-021-00088-6"},{"key":"2024043012151309000_2024.04.24.590997v1.11","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(22)00121-1"},{"key":"2024043012151309000_2024.04.24.590997v1.12","doi-asserted-by":"publisher","DOI":"10.1038\/35888"},{"key":"2024043012151309000_2024.04.24.590997v1.13","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-019-0205-0"},{"key":"2024043012151309000_2024.04.24.590997v1.14","doi-asserted-by":"crossref","first-page":"e266","DOI":"10.1038\/mtna.2015.38","article-title":"Hydrophobically Modified siRNAs Silence Huntingtin mRNA in Primary Neurons and Mouse Brain","volume":"4","year":"2015","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"2024043012151309000_2024.04.24.590997v1.15","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/j.ymthe.2023.05.006","article-title":"Di-valent siRNA-mediated silencing of MSH3 blocks somatic repeat expansion in mouse models of Huntington\u2019s disease","volume":"31","year":"2023","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther"},{"key":"2024043012151309000_2024.04.24.590997v1.16","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v067.i0"},{"key":"2024043012151309000_2024.04.24.590997v1.17","unstructured":"Lenth, R.V. , Bolker, B. , Buerkner, P. , Gin\u00e9-V\u00e1zquez, I. , Herve, M. , Jung, M. , Love, J. , Miguez, F. , Riebl, H. and Singmann, H. (2023) emmeans: Estimated Marginal Means, aka Least-Squares Means."},{"key":"2024043012151309000_2024.04.24.590997v1.18","doi-asserted-by":"publisher","DOI":"10.1021\/jm049167j"},{"key":"2024043012151309000_2024.04.24.590997v1.19","doi-asserted-by":"crossref","first-page":"7665","DOI":"10.1093\/nar\/gkaa595","article-title":"The chemical structure and phosphorothioate content of hydrophobically modified siRNAs impact extrahepatic distribution and efficacy","volume":"48","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"2024043012151309000_2024.04.24.590997v1.20","doi-asserted-by":"crossref","first-page":"7581","DOI":"10.1093\/nar\/gkx507","article-title":"5\u2019-Vinylphosphonate improves tissue accumulation and efficacy of conjugated siRNAs in vivo","volume":"45","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"2024043012151309000_2024.04.24.590997v1.21","doi-asserted-by":"publisher","DOI":"10.1101\/2023.05.26.542506"},{"key":"2024043012151309000_2024.04.24.590997v1.22","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkad1155"},{"key":"2024043012151309000_2024.04.24.590997v1.23","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.omtn.2020.06.006","article-title":"Cell Type Impacts Accessibility of mRNA to Silencing by RNA Interference","volume":"21","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"2024043012151309000_2024.04.24.590997v1.24","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv1206"},{"key":"2024043012151309000_2024.04.24.590997v1.25","unstructured":"Avidity Biosciences, Inc. (2024) A Randomized, Double-Blind, Placebo-Controlled, Phase 1\/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple-Doses of AOC 1001 Administered Intravenously to Adult Myotonic Dystrophy Type 1 (DM1) Patients clinicaltrials.gov ."},{"key":"2024043012151309000_2024.04.24.590997v1.26","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkm437"},{"key":"2024043012151309000_2024.04.24.590997v1.27","first-page":"406","article-title":"RNA-mediated toxicity in neurodegenerative disease","volume":"0","year":"2013","journal-title":"Mol. Cell. Neurosci"},{"key":"2024043012151309000_2024.04.24.590997v1.28","doi-asserted-by":"publisher","DOI":"10.1042\/BST20200143"},{"key":"2024043012151309000_2024.04.24.590997v1.29","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.276"},{"key":"2024043012151309000_2024.04.24.590997v1.30","doi-asserted-by":"publisher","DOI":"10.1038\/nature11233"},{"key":"2024043012151309000_2024.04.24.590997v1.31","doi-asserted-by":"crossref","first-page":"e2219523120","DOI":"10.1073\/pnas.2219523120","article-title":"Divalent siRNAs are bioavailable in the lung and efficiently block SARS-CoV-2 infection","volume":"120","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"2024043012151309000_2024.04.24.590997v1.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2011.09.011"},{"key":"2024043012151309000_2024.04.24.590997v1.33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42714-4"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2024.04.24.590997","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T06:20:48Z","timestamp":1768458048000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2024.04.24.590997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,28]]},"references-count":33,"URL":"https:\/\/doi.org\/10.1101\/2024.04.24.590997","relation":{},"subject":[],"published":{"date-parts":[[2024,4,28]]},"subtype":"preprint"}}